Rebecca A O'Brien from Denver, CO, age 47

Rebecca O'Brien - Lawyer

view source

Office:

O'Brien Cavanagh Ivanova LLP

Specialties:

Corporate & Incorporation

ISLN:

1000498978

Admitted:

2004

Law School:

University of California at Berkeley, Boalt Hall School of Law, JD - Juris Doctor, 2004

Professor At National Jewish Health

view source

Location:

Denver, CO

Industry:

Hospital & Health Care

Work:

National Jewish Health
Professor at National Jewish Health

Reporter

view source

Location:

50 Columbia St, Newark, NJ 07102

Industry:

Newspapers

Work:

The Wall Street Journal
Reporter
The Record Oct 2011 - Nov 2014
Reporter
Workman Publishing Aug 2009 - Oct 2011
Writer
Cities For Financial Empowerment Sep 2009 - Feb 2010
Consultant and Grant Administrator
Amg/Parade Oct 2008 - Sep 2009
Writer

Education:

Harvard University 2002 - 2006
Bachelors, Bachelor of Arts, Literature, History Harvard University;Ba, History and Literature;2002 – 2006;
Bachelors, Bachelor of Arts, Literature, History

Skills:

Writing
Editing
Investigative Reporting
Copy Editing
Blogging
Journalism
Online Journalism
Newspaper
News Writing
Ap Style
Editorial
Press Releases
Web Content
Newspapers
Feature Articles
Magazines
Publications
Breaking News
Storytelling

Languages:

English

Clinical Improvement Coach

view source

Industry:

Hospital & Health Care

Work:

Healthcare Association of Hawaii
Clinical Improvement Coach
Hhsc Kauai Region May 2009 - Jan 2016
Director of Quality
Kauai Veterans Memorial Hosp St Francis Home Care Services May 1993 - May 2009
Registered Nurse

Certifications:

Certified Professional of Healthcare Quality
Cphq

Partner

view source

Location:

4477 Wolff St, Denver, CO 80219

Industry:

Law Practice

Work:

Eaton Vance Jan 2010 - Jun 2010
Vice President and Counsel
Ropes & Gray LLP Sep 2004 - Dec 2009
Associate

Education:

University of California, Berkeley - School of Law 2001 - 2004
J.D., Law Harvard University 1997 - 2001
B.A., Government

Skills:

Mutual Funds
Legal Writing
Investment Management
Hedge Funds
Securities
Securities Regulation
Investments
Legal Research
Corporate Governance
Corporate Law

Clinical And Business Intelligence Analyst

view source

Location:

200 Tuckahoe Rd, Southampton, NY 11968

Industry:

Information Technology And Services

Work:

Cablevision
Sr Programmer Analyst
Cablevision Systems Corp. since 2009
Senior Programmer Analyst

Education:

Medstar Academy 2017 - 2018
City University of New York - Brooklyn College
Bachelors, Bachelor of Science

Skills:

Business Analysis
Integration
Process Improvement
Visio
Troubleshooting
Sql
Business Process Improvement
Software Project Management
Requirements Analysis
Software Documentation
It Strategy
Technical Support
Microsoft Office
Team Leadership
Business Intelligence
Cerner
Tableau
Software Development
Agile Project Management
Requirements Gathering
Functional Testing
Web Development
System Administration
Pl/Sql
Relational Databases
Crystal Reports
Training
Servicenow
Functional Specifications
Unit Testing
Business Process
Testing
Web Services
Quality Assurance
Pmp
Bmc Remedy
Software As A Service
Cross Functional Team Leadership
Computer Software Training
Powerinsight
Midas
Vendor Management
Sdlc
Telecommunications
Unix
Management
Linux
Disaster Recovery
Css
Program Management
Human Resources Information Systems
Html

Certifications:

Itil V3 Foundation
Registered Professional Nurse
License Rn 323140
New York State Department of Education, License Rn 323140

Rebecca O'brien

view source

Rebecca O'brien

view source

Rebecca O'brien

view source

Location:

United States

Us Patents

Devices And Formulations For Detecting, Screening And Monitoring Levels Of Certain Constituents In Bodily Fluids And Method
view source
US Patent:

8431386, Apr 30, 2013
Filed:

Sep 7, 2012
Appl. No.:

13/606299
Inventors:

Randice Lisa Altschul - Cliffside Park NJ, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:

Pop Test LLC - Cliffside Park NJ
International Classification:

C12M 1/34
US Classification:

4352871, 4352877, 4352887
Abstract:

A device is disclosed for conducting a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid. An indicator formulation of the device changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A carrier substrate of the device is constructed of a material having voids providing a high void volume within the substrate. The device is made by applying a chromagen to the carrier substrate to create a chromagen-laden carrier member. Then, a selected reagent having a particular constituent-specific formulation is applied to the chromagen-laden member. The selected reagent then combines with the chromagen, thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid.

Use Of Soluble Gammadelta T Cell Receptors For Regulating T Cell Function
view source
US Patent:

20030175212, Sep 18, 2003
Filed:

Jan 10, 2003
Appl. No.:

10/340536
Inventors:

Rebecca O'Brien - Denver CO, US
Willi Born - Denver CO, US
Christina Roark - Highlands Ranch CO, US
M. Aydintug - Thornton CO, US
International Classification:

A61K038/17
A61L009/04
US Classification:

424/045000, 514/012000
Abstract:

Disclosed is a method of using soluble T cell receptors to regulate a T cell-mediated immune response in a mammal.

Use Of Soluble Gammadelta Cell Receptors For Regulating T Cell Function
view source
US Patent:

20070269426, Nov 22, 2007
Filed:

Apr 3, 2007
Appl. No.:

11/695986
Inventors:

Rebecca O'Brien - Denver CO, US
Willi Born - Denver CO, US
Christina Roark - Highlands Ranch CO, US
M. Aydintug - Thornton CO, US
Assignee:

NATIONAL JEWISH MEDICAL AND RESEARCH CENTER - Denver CO
International Classification:

A61K 39/395
US Classification:

424131100
Abstract:

Disclosed is a method of using soluble γδ T cell receptors to regulate a γδ T cell-mediated immune response in a mammal.

Gamma Delta T Cells And Methods Of Treatment Of Interleukin-17 Related Conditions
view source
US Patent:

20080248025, Oct 9, 2008
Filed:

Mar 21, 2008
Appl. No.:

12/053310
Inventors:

Christina Roark - Englewood CO, US
Rebecca L. O'Brien - Denver CO, US
Willi K. Born - Denver CO, US
Assignee:

NATIONAL JEWISH MEDICAL AND RESEARCH CENTER - Denver CO
International Classification:

A61K 39/395
A61K 38/17
C12Q 1/02
A61P 35/00
A61P 37/00
US Classification:

4241301, 514 12, 435 29
Abstract:

This invention generally relates to methods to treat conditions and diseases associated with interleukin-17 (IL-17) production. The invention also relates to methods of inhibiting γδ T cells, and particularly, a subset of γδ T cells that produce IL-17.

Agents And Methods For Inhibition Of Airway Hyperresponsiveness
view source
US Patent:

20090028849, Jan 29, 2009
Filed:

Jul 24, 2008
Appl. No.:

12/178923
Inventors:

Rebecca L. O'Brien - Denver CO, US
Willi K. Born - Denver CO, US
Niyun Jin - Denver CO, US
Christina L. Roark - Englewood CO, US
International Classification:

A61K 39/395
A61K 38/17
A61P 11/00
US Classification:

4241301, 514 12, 424 9371
Abstract:

The present invention provides methods and compositions for inhibition of Airway Hyperresponsiveness (“AHR”) by deleting, inactivating or inhibiting a subset of innate γδ T cells, alone or in conjunction with the inhibition of Natural Killer T (“NKT”) cells. The methods comprise selective leukophoresis to remove the γδ T cells from the individual's blood or administration of an agent that selectively targets and inhibits or inactivates the γδ T cells. The methods of the present invention can be used to treat AHR in a variety of different ailments, including allergen-induced conditions or respiratory conditions and diseases.

Devices And Formulations For Detecting, Screening And Monitoring Levels Of Certain Constituents In Bodily Fluids And Method
view source
US Patent:

20120100563, Apr 26, 2012
Filed:

Oct 21, 2011
Appl. No.:

13/278306
Inventors:

Randice Lisa Altschul - Cliffside Park NJ, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:

POP TEST LLC - Cliffside Park NJ
International Classification:

C12Q 1/28
C12Q 1/60
C12Q 1/62
C12Q 1/54
US Classification:

435 10, 435 14, 435 11, 435 28
Abstract:

A device is disclosed for conducting a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid. An indicator formulation of the device changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A carrier substrate of the device is constructed of a material having voids providing a high void volume within the substrate.The device is made by applying a chromagen to the carrier substrate to create a chromagen-laden carrier member. Then, a selected reagent having a particular constituent-specific formulation is applied to the chromagen-laden member. The selected reagent then combines with the chromagen, thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid.

System And Method For Diagnosis And Treatment
view source
US Patent:

20120201747, Aug 9, 2012
Filed:

Feb 2, 2012
Appl. No.:

13/364651
Inventors:

Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:

POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:

A61K 31/58
A61K 51/00
A61K 31/7068
A61K 33/24
A61K 31/665
A61K 31/7076
A61K 38/12
A61K 31/704
A61K 38/50
A61P 25/24
A61P 25/18
A61P 5/00
A61P 35/02
C07J 17/00
G01N 33/566
G01N 33/53
C40B 30/04
A61N 5/00
A61J 1/05
A61P 35/00
B82Y 5/00
US Classification:

424 111, 514174, 514171, 514 49, 424649, 514110, 514 48, 514 192, 514 34, 514170, 424 946, 540116, 436501, 435 79, 506 9, 422430, 600 1, 604403, 977773, 977915
Abstract:

This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and/or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.

Combination Therapy
view source
US Patent:

20120245552, Sep 27, 2012
Filed:

Mar 21, 2012
Appl. No.:

13/425964
Inventors:

Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:

POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:

A61J 1/05
A61P 29/00
A61P 19/00
A61P 19/04
A61P 21/00
A61P 1/00
A61P 1/18
A61P 7/00
A61P 9/00
A61P 5/00
A61P 13/00
A61P 13/12
A61P 13/10
A61P 25/00
A61P 27/00
A61J 1/00
A61K 31/573
US Classification:

604403, 514171, 206438, 206570
Abstract:

This invention relates to compositions and methods for treating GC-responsive conditions and for reducing and preventing side-effects of GC treatment in patients.